Dashyant Dhanak

Executive Vice President & Chief Scientific Officer at Incyte Corp.

Dashyant Dhanak

Dashyant Dhanak

Executive Vice President & Chief Scientific Officer at Incyte Corp.

Biography

Dashyant Dhanak holds the position of Chief Scientific Officer & Executive VP at Incyte Corp. In the past Dr. Dhanak was Vice President of GlaxoSmithKline LLC and Vice President & Head-Discovery Sciences at Janssen Research & Development LLC. He received an undergraduate degree from the University of Manchester Institute of Science & Technology and a doctorate from the University of London.

Overview
RelSci Relationships

1957

Number of Boards

1

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals Dashyant Dhanak likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at Incyte Corp.

Relationship likelihood: Strong

Chief Executive Officer at American Association For Cancer Research Foundation

Relationship likelihood: Strong

Senior Program Coordinator, Associate Member Council at American Association for Cancer Research

Relationship likelihood: Strong

Director of Cancer Population Genetics at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Professor, Department of Medicine at Harvard University - Harvard Medical School

Relationship likelihood: Strong

Anne Burnett Windfohr Chair of Clinical Oncology at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Chief Scientific Officer at Van Andel Institute

Relationship likelihood: Strong

Member, Cancer Epigenome Task Force at American Association for Cancer Research

Relationship likelihood: Strong

Founder at Fulcrum Therapeutics, Inc.

Relationship likelihood: Strong

Member, Editorial Board at Oncogene

Relationship likelihood: Strong

In The News
Philadelphia Inquirer
October 11, 2021
INSIDER TRANSACTIONS
Philadelphia Inquirer
August 16, 2021
INSIDER TRANSACTIONS
Philadelphia Inquirer
June 21, 2021
INSIDER TRANSACTIONS
Philadelphia Inquirer
May 10, 2021
INSIDER TRANSACTIONS
Philadelphia Inquirer
February 15, 2021
INSIDER TRANSACTIONS
Paths to Dashyant Dhanak
Potential Connections via
Relationship Science
You
Dashyant Dhanak
Executive Vice President & Chief Scientific Officer at Incyte Corp.
Education

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

University of Manchester Institute of Science and Technology specializes in technical and scientific subjects.

Career History
Executive Vice President & Chief Scientific Officer
2018 - Current

Incyte's vision is to become a leading drug discovery, development and commercial company by building a proprietary product pipeline of novel small molecule drugs for serious unmet medical needs. We have experienced management, discovery, clinical development and commercial teams. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in health care, improve the lives of patients and build sustainable value for our shareholders. Our pipeline is focused on oncology and inflammation and includes compounds in various stages of development. Our lead product, Jakafi® (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the United States for the treatment of intermediate or high-risk myelofibrosis (please see Full Prescribing Information and Important Safety Information for Jakafi) and is in development as a potential treatment for other cancers. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. Through strategic collaborations with Novartis and Eli Lilly, we are advancing the global development of two of our JAK1 and JAK2 inhibitor programs. Incyte's corporate headquarters is located in Wilmington, Delaware

Vice President & Head-Discovery Sciences
2013 - 2018

Part of Johnson & Johnson, Janssen Research & Development LLC is a company headquartered in Raritan, NJ, that provides research and development medicines and solutions to other medical needs.The company says this about itself: At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen Research & Development is part of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Vice President
Prior

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dashyant Dhanak. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dashyant Dhanak's profile does not indicate a business or promotional relationship of any kind between RelSci and Dashyant Dhanak.